malignant pleural effusion 中文意思是什麼

malignant pleural effusion 解釋
惡性腫瘤性胸腔積液
  • malignant : adj 1 有惡意的；惡毒的。2 惡性的（疾病等）（opp benignant）。3 有害的；邪惡的；不吉利的。4 【英史...
  • pleural : 側板的
  • effusion : n. 1. 噴發，溢出，流出；滲出物；【醫學】滲出；【機械工程】瀉流。2. 顯露，流露，吐露（心情等）。
  1. Effect of interleukin - 2 and pdd in treatment of malignant pleural effusion

    聯合順鉑治療惡性胸腔積液
  2. Intrapleural instillation with ok - 432 and hydroxycamptothecin for malignant pleural effusion

    治療惡性胸腔積液的對照觀察
  3. Intrapleural instillation of cisplatin and interleukin - 2 in the treatment for malignant pleural effusion

    順鉑聯合白細胞介素2腔內治療惡性胸腔積液
  4. Diagnostic value of cd1a and ifn - in tuberculous and malignant pleural effusion

    對惡性和結核性胸腔積液的診斷價值
  5. Clinical observation on malignant pleural effusion treated by intrapleural perfusion of staphylococcal entero toxin combined with hydroxycamptothecin

    香菇多糖聯合羥基喜樹堿治療癌性胸腔積液臨床觀察
  6. Malignant pleural effusion treated with etoposide, cisplatin and tale

    滑石粉聯合治療惡性胸腔積液的研究
  7. Intrapleural therapy with ok - 432 and hcpt in malignant pleural effusion

    局部灌注沙培林和羥基喜樹堿治療惡性胸腔積液
  8. Clinical observation on ok - 432 in treatment of malignant pleural effusion induced by lung cancer in elderly

    沙培林治療老年肺癌所致惡性胸腔積液的療效觀察
  9. Objective to observe the clinical effects of 36 patients with malignant pleural effusion tredted by streptococcus a group for injection

    摘要目的：觀察沙培林治療惡性胸腔積液的臨床療效。
  10. The value of c - reactive protein in differential tuberculous pleural effusion from malignant pleural effusion

    檢測腺苷脫氨酶和血清結核抗體鑒別胸腔積液的價值探討
  11. Methods 60 patients with malignant pleural effusion were randomly divided into trial group and control group, and each group was 30 patients

    方法將60例惡性胸腔積液患者隨機分為觀察組和對照組（各30例） 。
  12. Brucea javanica oil emulsion in the treatment for 40 cases with malignant pleural effusion

    鴉膽子油乳治療40例惡性胸腔積液
  13. Conclusions there are some surely therapeutic effect for cisplatin combination with thymopentin on patients with malignant pleural effusion, and it can improve their quality of life ( qol )

    結論順鉑聯合胸腺五肽治療惡性胸腔積液有確切療效，明顯提高化療藥物敏感性，進而提高患者的生活質量。
  14. Clinical analysis of lifein in treatment of malignant pleural effusion

    力爾凡治療惡性胸腔積液的臨床分析
  15. Malignant pleural effusion basically occurs in intermediate stage and late stage of malignant tumor, and its aim of treatment is to alleviate the patient ' s suffering, elevate patient, s life quality and lengthen patient, s life. with the development of science and technology, therapeutic measure is improving gradually. but the long - term effect need to be enhanced

    惡性胸液在臨床上基本上都出現在腫瘤的中、晚期，治療的主要目的是解決患者的痛苦、提高病人的生存質量、延長患者的生命，其治療措施隨著科技的進步也在不斷地改進完善，遠期效果將有待于進一步提高。
  16. Cisplatin combined with interleukin - 2 in the treatment for malignant pleural effusion

    順鉑聯合白細胞介素2治療惡性胸水
  17. Treatment of malignant pleural effusion using cisplatin and il - 2 into pleural cavity

    2治療惡性胸腔積液32例
  18. Treatment of malignant pleural effusion by intrathoracic houttuymia injection : a clinical observation 20 cases

    魚腥草注射液胸腔內注射治療惡性胸腔積液20例療效觀察
  19. Clinical research of drainage with microcatheter and intrathoracic cavity drug therapy for malignant pleural effusion

    胸腔內置管引流及藥物治療惡性胸腔積液的臨床觀察
  20. Objective to observe the curative effect of cisplatin on malignant pleural effusion combined with thymopentin at patients

    摘要目的觀察順鉑聯合胸腺五肽治療惡性胸腔積液的療效。
分享友人
分享到 Line

分享到臉書